ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Almirall, S.A. clinical trials

Part of Grupo Corporativo Landon, S.L., which holds 59.88% of voting rights as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 74 studies whose lead sponsor is Almirall, S.A. or the company grouped under it. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare Almirall with Pfizer and Innovent Biologics →

Pipeline: 5 programs

Each counted once: 5 with a study Almirall, S.A. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Almirall, S.A.’s own registered studies; Almirall, S.A.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Almirall, S.A.’s studies test, most open studies first — 17 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 7 more

Coming up

6 of Almirall, S.A.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. M
  6. 1A
  7. 2M
  8. 1J
  9. 1J
  10. A
  11. S
  12. O
  13. N

Add all 6 to your calendar (.ics) → With an account.

All 74 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now912%Recruiting 8 · Not yet recruiting 1
  • Under way, not recruiting34%
  • Completed5980%
  • Stopped early34%Withdrawn 2 · Terminated 1

Phase

  • Phase 328
  • Phase 218
  • Phase 110
  • Phase 48

Where

  • Germany34
  • United States21
  • Spain13
  • United Kingdom10
  • Poland9
  • Italy8

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 1014
  8. 15
  9. 16
  10. 17
  11. 18
  12. 19
  13. 20
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 426

By the year each study started; 1 started before 2008. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Almirall, S.A.

  • Almirall, S.A.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    66 studies
  • Polichem S.A.
    Acquired — became part of Almirall, S.A., Feb 5, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Almirall, SAS
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study

Focus areas

Conditions Almirall, S.A. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 74. Browse all 74 →